TY - JOUR
T1 - Age-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease
AU - Chua, Jacqueline
AU - Zhang, Zheting
AU - Wong, Damon
AU - Tan, Bingyao
AU - Kulantayan, Bhavani
AU - Sng, Chelvin C.A.
AU - Hilal, Saima
AU - Venketasubramanian, Narayanaswamy
AU - Tan, Boon Yeow
AU - Cheung, Carol Y.
AU - Garhöfer, Gerhard
AU - Popa-Cherecheanu, Alina
AU - Wong, Tien Yin
AU - Chen, Christopher Li Hsian
AU - Schmetterer, Leopold
N1 - Publisher Copyright:
Copyright © 2022 Chua, Zhang, Wong, Tan, Kulantayan, Sng, Hilal, Venketasubramanian, Tan, Cheung, Garhöfer, Popa-Cherecheanu, Wong, Chen and Schmetterer.
PY - 2022/7/14
Y1 - 2022/7/14
N2 - Introduction: Alzheimer's disease (AD) and age-related eye diseases pose an increasing burden as the world's population ages. However, there is limited understanding on the association of AD/cognitive impairment, no dementia (CIND) with age-related eye diseases. Methods: In this cross-sectional, memory clinic-based study of multiethnic Asians aged 50 and above, participants were diagnosed as AD (n = 216), cognitive impairment, no dementia (CIND) (n = 252), and no cognitive impairment (NCI) (n = 124) according to internationally accepted criteria. Retinal photographs were graded for the presence of age-related macular degeneration (AMD) and diabetic retinopathy (DR) using standard grading systems. Multivariable-adjusted logistic regression models were used to determine the associations between neurological diagnosis and odds of having eye diseases. Results: Over half of the adults had at least one eye disease, with AMD being the most common (60.1%; n = 356), followed by DR (8.4%; n = 50). After controlling for age, sex, race, educational level, and marital status, persons with AD were more likely to have moderate DR or worse (OR = 2.95, 95% CI = 1.15–7.60) compared with NCI. In the fully adjusted model, the neurological diagnosis was not associated with AMD (OR = 0.75, 95% CI = 0.45–1.24). Conclusion: Patients with AD have an increased odds of having moderate DR or worse, which suggests that these vulnerable individuals may benefit from specific social support and screening for eye diseases.
AB - Introduction: Alzheimer's disease (AD) and age-related eye diseases pose an increasing burden as the world's population ages. However, there is limited understanding on the association of AD/cognitive impairment, no dementia (CIND) with age-related eye diseases. Methods: In this cross-sectional, memory clinic-based study of multiethnic Asians aged 50 and above, participants were diagnosed as AD (n = 216), cognitive impairment, no dementia (CIND) (n = 252), and no cognitive impairment (NCI) (n = 124) according to internationally accepted criteria. Retinal photographs were graded for the presence of age-related macular degeneration (AMD) and diabetic retinopathy (DR) using standard grading systems. Multivariable-adjusted logistic regression models were used to determine the associations between neurological diagnosis and odds of having eye diseases. Results: Over half of the adults had at least one eye disease, with AMD being the most common (60.1%; n = 356), followed by DR (8.4%; n = 50). After controlling for age, sex, race, educational level, and marital status, persons with AD were more likely to have moderate DR or worse (OR = 2.95, 95% CI = 1.15–7.60) compared with NCI. In the fully adjusted model, the neurological diagnosis was not associated with AMD (OR = 0.75, 95% CI = 0.45–1.24). Conclusion: Patients with AD have an increased odds of having moderate DR or worse, which suggests that these vulnerable individuals may benefit from specific social support and screening for eye diseases.
KW - age-related macular degeneration
KW - Alzheimer's disease
KW - cognitive impairment no dementia
KW - dementia
KW - diabetic retinopathy
UR - http://www.scopus.com/inward/record.url?scp=85135036285&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135036285&partnerID=8YFLogxK
U2 - 10.3389/fnagi.2022.933853
DO - 10.3389/fnagi.2022.933853
M3 - Article
AN - SCOPUS:85135036285
SN - 1663-4365
VL - 14
JO - Frontiers in Aging Neuroscience
JF - Frontiers in Aging Neuroscience
M1 - 933853
ER -